Annual report pursuant to Section 13 and 15(d)

Loss Per Share - Schedule of anti-dilutive securities (Details)

v3.24.1
Loss Per Share - Schedule of anti-dilutive securities (Details) - shares
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total excluded from computation of diluted weighted-average shares (in shares) 14,019,034 11,299,681
Common stock warrants    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total excluded from computation of diluted weighted-average shares (in shares) 4,372,757 2,801,703
Stock options    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total excluded from computation of diluted weighted-average shares (in shares) 9,342,589 8,234,823
Restricted stock units    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total excluded from computation of diluted weighted-average shares (in shares) 303,688 263,155